335 related articles for article (PubMed ID: 27566970)
21. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden.
Kågström E; Lannergård A; El Khosht J; Lörelius P; Månflod J; Strömdahl S
Harm Reduct J; 2023 Jun; 20(1):77. PubMed ID: 37328868
[TBL] [Abstract][Full Text] [Related]
23. Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries.
Jarlais DD
J Food Drug Anal; 2013 Dec; 21(4):S59-S61. PubMed ID: 25267887
[TBL] [Abstract][Full Text] [Related]
24. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
25. Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
O'Keefe D; Aitken C; Scott N; Dietze P
Drug Alcohol Depend; 2018 Oct; 191():259-265. PubMed ID: 30153607
[TBL] [Abstract][Full Text] [Related]
26. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of harm reduction.
Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
[TBL] [Abstract][Full Text] [Related]
28. Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.
Davis SM; Daily S; Kristjansson AL; Kelley GA; Zullig K; Baus A; Davidov D; Fisher M
Harm Reduct J; 2017 May; 14(1):25. PubMed ID: 28514954
[TBL] [Abstract][Full Text] [Related]
29. Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.
Killion JA; Magana C; Cepeda JA; Vo A; Hernandez M; Cyr CL; Heskett KM; Wilson DP; Graff Zivin J; Zúñiga ML; Pines HA; Garfein RS; Vickerman P; Terris-Prestholt F; Wynn A; Martin NK
AIDS; 2023 Dec; 37(15):2389-2397. PubMed ID: 37773035
[TBL] [Abstract][Full Text] [Related]
30. "No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.
Walker S; Curtis M; Kirwan A; Thatcher R; Dietze P
Harm Reduct J; 2024 Feb; 21(1):51. PubMed ID: 38402389
[TBL] [Abstract][Full Text] [Related]
31. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
[TBL] [Abstract][Full Text] [Related]
32. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
[TBL] [Abstract][Full Text] [Related]
33. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
Deryabina A; El-Sadr WM
Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
[TBL] [Abstract][Full Text] [Related]
34. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
Topp L; Day CA; Iversen J; Wand H; Maher L;
AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
[TBL] [Abstract][Full Text] [Related]
35. Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis.
Tran LT; Peacock A; Colledge S; Memedovic S; Grebely J; Leung J; Larney S; Trickey A; Stone J; Vickerman P; Hickman M; Degenhardt L
Int J Drug Policy; 2020 Oct; 84():102866. PubMed ID: 32712484
[TBL] [Abstract][Full Text] [Related]
36. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.
Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S
Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
[TBL] [Abstract][Full Text] [Related]
38. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
39. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
